ABATE, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 327
EU - Europa 314
AS - Asia 179
SA - Sud America 61
OC - Oceania 12
AF - Africa 1
Totale 894
Nazione #
US - Stati Uniti d'America 321
IT - Italia 129
RU - Federazione Russa 98
SG - Singapore 82
BR - Brasile 57
CN - Cina 39
VN - Vietnam 36
IE - Irlanda 18
DE - Germania 15
GB - Regno Unito 12
NL - Olanda 12
SE - Svezia 12
AU - Australia 8
KR - Corea 7
AT - Austria 5
FI - Finlandia 5
CZ - Repubblica Ceca 4
IN - India 4
NZ - Nuova Zelanda 4
MX - Messico 3
AR - Argentina 2
BD - Bangladesh 2
CA - Canada 2
HK - Hong Kong 2
IQ - Iraq 2
PL - Polonia 2
TR - Turchia 2
UA - Ucraina 2
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
IR - Iran 1
KW - Kuwait 1
MA - Marocco 1
UZ - Uzbekistan 1
Totale 894
Città #
Chandler 60
Princeton 53
Singapore 39
West Jordan 37
Dong Ket 34
Naples 32
Ashburn 28
Dublin 17
Beijing 15
Moscow 15
Lecce 14
Nuremberg 8
Andover 7
Los Angeles 6
Milan 6
Rome 6
Wilmington 6
Amsterdam 5
Ann Arbor 5
Boardman 4
Bologna 4
Brno 4
Curitiba 4
Romano di Lombardia 4
Seattle 4
Sydney 4
Belo Horizonte 3
Dallas 3
Jacksonville 3
Marigliano 3
Menlo Park 3
New York 3
Norwalk 3
Pune 3
São Paulo 3
Washington 3
Assago 2
Boston 2
Brasília 2
Casavatore 2
Charlotte 2
Chełmża 2
College Park 2
Eboli 2
Fortaleza 2
Gaeta 2
Genoa 2
Helsinki 2
Hong Kong 2
Mauá 2
Mexico City 2
Monza 2
Munich 2
Nürnberg 2
Pittsburgh 2
Redwood City 2
Rio de Janeiro 2
Santa Clara 2
Shanghai 2
The Dalles 2
Turku 2
Abaetetuba 1
Adelaide 1
Agadir 1
Ananindeua 1
Andrelândia 1
Araxá 1
Arcoverde 1
As Sālimīyah 1
Auckland 1
Ayr 1
Balbriggan 1
Baltimore 1
Belo Jardim 1
Betim 1
Birmingham 1
Bradford 1
Brampton 1
Calmon 1
Campina Grande do Sul 1
Campinas 1
Campo Grande 1
Cerrillo de Catemu 1
Christchurch 1
Cleveland 1
Cotia 1
Diadema 1
Duque de Caxias 1
Durham 1
Edinburgh 1
Epsom 1
Erbil 1
Fairfield 1
Franca 1
Frattaminore 1
Garland 1
Grão Mogol 1
Guarulhos 1
Guayaquil 1
Hamilton 1
Totale 540
Nome #
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 82
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 78
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 58
Midbrain MRI assessments in progressive supranuclear palsy subtypes 55
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 54
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 51
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 51
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 49
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 48
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 45
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 40
Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome 37
Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy 33
Performing a short sway to distinguish Parkinsonisms 32
Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy 28
The “zig-zag” sign in Progressive Supranuclear Palsy 28
Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages 28
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 26
Frequency and imaging correlates of neuropsychiatric symptoms in Progressive Supranuclear Palsy 25
Brittle response to levodopa as a marker of Parkinson’s disease phenotype characterized by heavy motor and non-motor burden 17
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 17
Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis 16
Direct Current Stimulation of Prefrontal Cortex Is Not Effective in Progressive Supranuclear Palsy: A Randomized Trial 15
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 15
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 14
Totale 942
Categoria #
all - tutte 5.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/202154 2 0 0 2 8 0 5 0 3 0 0 34
2021/202290 2 1 0 8 7 0 2 3 10 10 8 39
2022/2023159 15 22 16 14 8 23 8 14 24 2 9 4
2023/2024196 4 13 9 17 11 22 12 9 16 50 12 21
2024/2025437 3 3 4 31 33 42 114 30 50 31 56 40
Totale 942